Works by Panaccione, R.

Results: 39

A framework for clinical care pathway renewal: an example from inflammatory bowel disease.

Published in:

BMC Medical Research Methodology, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12874-025-02616-z

By:

Chappell, K. D.;
Olayinka, L.;
Sutton, R.;
Seow, C. H.;
deBruyn, J.;
van Zanten, S. V.;
Ma, C.;
Halloran, B.;
Dieleman, L. A.;
Wong, K.;
Panaccione, R.;
Kroeker, K. I.

Publication type:

Article

Multimodal Immunosuppressant Therapy in Steroid-Refractory Common Variable Immunodeficiency Sprue: A Case Report Complicating Cytomegalovirus Infection.

Published in:

International Journal of Surgical Pathology, 2006, v. 14, n. 1, p. 101, doi. 10.1177/106689690601400120

By:

Medlicott, S. A. C.;
Coderre, S.;
Horne, G.;
Panaccione, R.

Publication type:

Article

Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 12, p. 1578, doi. 10.1111/apt.14672

By:

Ma, C.;
Guizzetti, L.;
Panaccione, R.;
Fedorak, R. N.;
Pai, R. K.;
Parker, C. E.;
Nguyen, T. M.;
Khanna, R.;
Vande Casteele, N.;
D'Haens, G.;
Sandborn, W. J.;
Feagan, B. G.;
Jairath, V.

Publication type:

Article

Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 219, doi. 10.1111/apt.14420

By:

Colombel, J.‐F.;
Sandborn, W. J.;
Reinisch, W.;
Peyrin‐Biroulet, L.;
Panaccione, R.;
Rutgeerts, P.;
Hanauer, S. B.;
Ghosh, S.;
Van Assche, G.;
Robinson, A. M.;
Lau, W.;
Maa, J.‐F.;
Huang, B.;
Pappalardo, B.;
Read, H.

Publication type:

Article

Editorial: different tests for different drugs in Crohn's disease, or different tests for different people?

Published in:

2017

By:

Seow, C. H.;
Panaccione, R.

Publication type:

Editorial

The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 10, p. 1329, doi. 10.1111/apt.14040

By:

Seow, C. H.;
Leung, Y.;
Vande Casteele, N.;
Ehteshami Afshar, E.;
Tanyingoh, D.;
Bindra, G.;
Stewart, M. J.;
Beck, P. L.;
Kaplan, G. G.;
Ghosh, S.;
Panaccione, R.

Publication type:

Article

Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort.

Published in:

Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 9, p. 1232, doi. 10.1111/apt.14016

By:

Ma, C.;
Fedorak, R. N.;
Kaplan, G. G.;
Dieleman, L. A.;
Devlin, S. M.;
Stern, N.;
Kroeker, K. I.;
Seow, C. H.;
Leung, Y.;
Novak, K. L.;
Halloran, B. P.;
Huang, V. W.;
Wong, K.;
Blustein, P. K.;
Ghosh, S.;
Panaccione, R.

Publication type:

Article

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 10, p. 1236, doi. 10.1111/apt.12499

By:

Panaccione, R.;
Colombel, J.‐F.;
Sandborn, W. J.;
D'Haens, G.;
Zhou, Q.;
Pollack, P. F.;
Thakkar, R. B.;
Robinson, A. M.

Publication type:

Article

Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 9, p. 1002, doi. 10.1111/apt.12491

By:

Moran, G. W.;
Lim, A. W. K.;
Bailey, J. L.;
Dubeau, M.‐F.;
Leung, Y.;
Devlin, S. M.;
Novak, K.;
Kaplan, G. G.;
Iacucci, M.;
Seow, C.;
Martin, L.;
Panaccione, R.;
Ghosh, S.

Publication type:

Article

Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 5, p. 447, doi. 10.1111/apt.12407

By:

Khanna, R.;
Sattin, B. D.;
Afif, W.;
Benchimol, E. I.;
Bernard, E.‐J.;
Bitton, A.;
Bressler, B.;
Fedorak, R. N.;
Ghosh, S.;
Greenberg, G. R.;
Marshall, J. K.;
Panaccione, R.;
Seidman, E. G.;
Silverberg, M. S.;
Steinhart, A. H.;
Sy, R.;
Van Assche, G.;
Walters, T. D.;
Sandborn, W. J.;
Feagan, B. G.

Publication type:

Article

Commentary: detection of infliximab levels and anti-infliximab antibodies.

Published in:

Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 1, p. 153, doi. 10.1111/apt.12107

By:

Seow, C. H.;
Panaccione, R.

Publication type:

Article

Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 3, p. 306, doi. 10.1111/j.1365-2036.2011.04717.x

By:

Kamm, M. A.;
Hanauer, S. B.;
Panaccione, R.;
Colombel, J.‐F.;
Sandborn, W. J.;
Pollack, P. F.;
Zhou, Q.;
Robinson, A. M.

Publication type:

Article

Review article: defining remission in ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 2, p. 113, doi. 10.1111/j.1365-2036.2011.04701.x

By:

Travis, S. P. L.;
Higgins, P. D. R.;
Orchard, T.;
Van Der Woude, C. J.;
Panaccione, R.;
Bitton, A.;
O'Morain, C.;
Panés, J.;
Sturm, A.;
Reinisch, W.;
Kamm, M. A.;
D'Haens, G.

Publication type:

Article

Novel concepts in inflammatory bowel disease.

Published in:

British Medical Bulletin, 2014, v. 109, n. 1, p. 55, doi. 10.1093/bmb/ldt039

By:

Moran, G. W.;
Dubeau, M. F.;
Kaplan, G. G.;
Panaccione, R.;
Ghosh, S.

Publication type:

Article

A173 INNOVATIVE CARE FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: USE OF BEDSIDE INTESTINAL ULTRASOUND TO OPTIMIZE MANAGEMENT.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 184, doi. 10.1093/jcag/gwab002.171

By:

Novak, K L;
Ma, C;
Kheirkhahrahimabadi, H;
heatherington, j;
Ingram, R;
Martin, M;
Panaccione, R;
Kaplan, G G;
Devlin, S;
Seow, C;
Chan, M;
Lu, C

Publication type:

Article

A155 REAL-WORLD USE OF CORTIMENT IN ULCERATIVE COLITIS: A POPULATION-BASED STUDY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 161, doi. 10.1093/jcag/gwab002.153

By:

Coward, S;
Martins, K;
Klarenbach, S;
Kroeker, K;
Ma, C;
Panaccione, R;
Richer, L;
Seow, C;
Targownik, L E;
Kaplan, G G

Publication type:

Article

A123 DEFINING CROHN'S DISEASE STRICTURES USING INTESTINAL ULTRASOUND COMPARED TO HISTOPATHOLOGY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 104, doi. 10.1093/jcag/gwab002.121

By:

Cooper, J;
Koro, K;
Wilson, S;
Medellin, A;
Ma, C;
Novak, K L;
Seow, C;
Kaplan, G G;
Panaccione, R;
Lu, C

Publication type:

Article

A92 PREVIOUS VIRTUAL CONSULTATION EXPERIENCE IS RELATED TO PRECEPTOR'S WILLINGNESS TO INVOLVE TRAINEES IN VIRTUAL CARE DURING THE COVID-19 PANDEMIC.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 65, doi. 10.1093/jcag/gwab002.090

By:

Olayinka, L;
Kaplan, G G;
Reeb, L;
Panaccione, R;
Kroeker, K

Publication type:

Article

A87 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 57, doi. 10.1093/jcag/gwab002.085

By:

Olayinka, L;
Kaplan, G G;
Reeb, L;
Panaccione, R;
Kroeker, K

Publication type:

Article

A80 IMPACT OF THE COVID-19 PANDEMIC IN IBD PATIENT CARE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 48, doi. 10.1093/jcag/gwab002.078

By:

Dahiya, M;
Olayinka, L;
Kaplan, G G;
Reeb, L;
Ma, C;
Panaccione, R;
Kroeker, K

Publication type:

Article

A18 DIETARY PREDICTORS OF BIOLOGICAL ACTIVITY IN CROHN'S DISEASE: A RETROSPECTIVE COHORT STUDY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 23, doi. 10.1093/jcag/gwab002.017

By:

Chiu, E;
Zhang, Z;
Taylor, L;
Kaur, S;
Ghosh, S;
Panaccione, R;
Reimer, R;
Raman, M

Publication type:

Article

A216 UC NARRATIVE CANADIAN DATA – COMPARING PATIENT AND PHYSICIAN PERSPECTIVES ON COMMUNICATION AND MANAGEMENT OF ULCERATIVE COLITIS.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 422, doi. 10.1093/jcag/gwz006.215

By:

Panaccione, R;
Mawani, M;
Kayhan, C;
Wosik, K

Publication type:

Article

A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 396, doi. 10.1093/jcag/gwz006.201

By:

Sandborn, W J;
Panés, J;
Panaccione, R;
D'Haens, G;
Sands, B E;
Su, C;
Moscariello, M;
Jones, T V;
Pedersen, R D;
Friedman, G S;
Lawendy, N;
Chan, G

Publication type:

Article

A133 PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE IS NOT ASSOCIATED WITH MORE DISABILITY COMPARED TO ADULT ONSET DISEASE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 266, doi. 10.1093/jcag/gwz006.132

By:

Picardo, S;
Panaccione, R;
Kaplan, G G;
Seow, C;
deBruyn, J;
Leung, Y

Publication type:

Article

A124 IMPROVEMENT IN DISEASE ACTIVITY IS ASSOCIATED WITH LESS DISABILITY IN A PROSPECTIVE STUDY OF PEDIATRIC TRANSITION PATIENTS WITH IBD.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 249, doi. 10.1093/jcag/gwz006.123

By:

Picardo, S;
Panaccione, R;
Kaplan, G G;
Seow, C;
deBruyn, J;
Leung, Y

Publication type:

Article

A122 COMBINATION BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: THE CALGARY EXPERIENCE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 244, doi. 10.1093/jcag/gwz006.121

By:

Panaccione, N;
Novak, K L;
Seow, C;
Devlin, S;
Lu, C;
Heatherington, J;
Kaplan, G G;
Panaccione, R

Publication type:

Article

A91 UNMET NEEDS OF INFLAMMATORY BOWEL DISEASE PATIENTS IN CANADA: RESULTS OF A WEB SURVEY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 181, doi. 10.1093/jcag/gwz006.090

By:

Gray, J R;
Attara, G;
Aumais, G;
Panaccione, R;
Marshall, J

Publication type:

Article

A68 COST EFFECTIVENESS OF TIGHT CONTROL FOR CROHN'S DISEASE WITH ADALIMUMAB-BASED TREATMENT: ECONOMIC EVALUATION OF CALM TRIAL FROM CANADIAN PERSPECTIVE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 136, doi. 10.1093/jcag/gwz006.067

By:

Panaccione, R;
Colombel, J;
Bossuyt, P;
Baert, F;
Vanasek, T;
Danalioglu, A;
Novacek, G;
Armuzzi, A;
Reinisch, W;
Johnson, S;
Buessing, M;
Neimark, E;
Petersson, J;
Robinson, A M;
Thakkar, R B;
Lee, W;
Skup, M;
D'Haens, G

Publication type:

Article

A31 GLOBAL BURDEN OF HOSPITALIZATION FOR PERSONS WITH IBD IN THE 21ST CENTURY: TIME TREND ANALYSES.

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 61, doi. 10.1093/jcag/gwz006.030

By:

Windsor, J W;
Buie, M;
Coward, S;
King, J A;
Underwood, F;
Quan, J;
Panaccione, R;
Seow, C;
Kaplan, G G

Publication type:

Article

A29 THE EVOLVING INCIDENCE OF INFLAMMATORY BOWEL DISEASE: WHAT WILL THE FUTURE HOLD?

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 56, doi. 10.1093/jcag/gwz006.028

By:

Coward, S;
Benchimol, E I;
Clement, F;
Hazlewood, G;
Kuenzig, E;
McBrien, K;
Deardon, R;
Panaccione, R;
Seow, C;
Windsor, J W;
Kaplan, G G

Publication type:

Article

A13 PROTEINS AND FIBROSTENOTIC CROHN'S DISEASE; WHO SHOWED UP TO THE PARTY?

Published in:

Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 26, doi. 10.1093/jcag/gwz006.012

By:

Lu, C;
Dufour, A;
Ueno, A;
Jijon, H;
Prowse, K;
Novak, K L;
Panaccione, R;
Hirota, S A

Publication type:

Article

Adverse Events and Nocebo Effects in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Published in:

Journal of Crohn's & Colitis, 2019, v. 13, n. 9, p. 1201, doi. 10.1093/ecco-jcc/jjz087

By:

Ma, Christopher;
Panaccione, Nicola R;
Nguyen, Tran M;
Guizzetti, Leonardo;
Parker, Claire E;
Hussein, Isra M;
Casteele, Niels Vande;
Khanna, Reena;
Dulai, Parambir S;
Singh, Siddharth;
Feagan, Brian G;
Jairath, Vipul

Publication type:

Article

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 12, p. 1296, doi. 10.1111/j.1365-2036.2010.04304.x

By:

PANACCIONE, R.;
COLOMBEL, J.‐F.;
SANDBORN, W. J.;
RUTGEERTS, P.;
D'HAENS, G. R.;
ROBINSON, A. M.;
CHAO, J.;
MULANI, P. M.;
POLLACK, P. F.

Publication type:

Article

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2010, v. 31, n. 1, p. 20, doi. 10.1111/j.1365-2036.2009.04112.x

By:

SHALE, M. J.;
SEOW, C. H.;
COFFIN, C. S.;
KAPLAN, G. G.;
PANACCIONE, R.;
GHOSH, S.

Publication type:

Article

Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab.

Published in:

Alimentary Pharmacology & Therapeutics, 2009, v. 30, n. 10, p. 977, doi. 10.1111/j.1365-2036.2009.04101.x

By:

MA, C.;
PANACCIONE, R.;
HEITMAN, S. J.;
DEVLIN, S. M.;
GHOSH, S.;
KAPLAN, G. G.

Publication type:

Article

Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.

Published in:

Alimentary Pharmacology & Therapeutics, 2008, v. 28, n. 6, p. 674, doi. 10.1111/j.1365-2036.2008.03753.x

By:

PANACCIONE, R.;
RUTGEERTS, P.;
SANDBORN, W. J.;
FEAGAN, B.;
SCHREIBER, S.;
GHOSH, S.

Publication type:

Article

Reduction in surgical stoma rates in Crohn's disease: a population‐based time trend analysis.

Published in:

Colorectal Disease, 2019, v. 21, n. 11, p. 1279, doi. 10.1111/codi.14731

By:

Ma, C.;
Almutairdi, A.;
Tanyingoh, D.;
Seow, C. H.;
Novak, K. L.;
Lu, C.;
Panaccione, R.;
Kaplan, G. G.;
Kotze, P. G.

Publication type:

Article

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

Published in:

2007

By:

Sandborn WJ;
Rutgeerts P;
Enns R;
Hanauer SB;
Colombel J;
Panaccione R;
D'Haens G;
Li J;
Rosenfeld MR;
Kent JD;
Pollack PF;
Sandborn, William J;
Rutgeerts, Paul;
Enns, Robert;
Hanauer, Stephen B;
Colombel, Jean-Frédéric;
Panaccione, Remo;
D'Haens, Geert;
Li, Ju;
Rosenfeld, Marie R

Publication type:

journal article

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Published in:

American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 9, p. 1324, doi. 10.1038/ajg.2015.233

By:

Peyrin-Biroulet, L;
Sandborn, W;
Sands, B E;
Reinisch, W;
Bemelman, W;
Bryant, R V;
D'Haens, G;
Dotan, I;
Dubinsky, M;
Feagan, B;
Fiorino, G;
Gearry, R;
Krishnareddy, S;
Lakatos, P L;
Loftus Jr, E V;
Marteau, P;
Munkholm, P;
Murdoch, T B;
Ordás, I;
Panaccione, R

Publication type:

Article